✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹251 Cr.
P/E
73.16

Key Ratios

Market cap
Market cap
251 Cr
PE
PE
73.16
Prom Holding
Prom Holding
37.71 %
ROE (%)
ROE (%)
2.91
ROCE (%)
ROCE (%)
7.61
Div Yield (%)
Div Yield (%)
-
Sales
Sales
390 Cr
OPM (%)
OPM (%)
-0.35 %
Debt to Equity
Debt to Equity
0.26
Institutions
Institutions
4.18 %
Individual < 2 lac
Individual < 2 lac
16.69 %
No. of Shareholders
No. of Shareholders
14,188

About

Aarey Drugs & Pharmaceuticals Ltd.is engaged in the manufacturing of drugs and intermediates s… Read more
Low
48
52W Range
High
100
  • Aarey Drugs & Pharma
  • Syschem (India)
  • Everest Organics

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

Edit rows

Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

7 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

FAQs on Aarey Drugs & Pharmaceuticals Ltd. Business

Aarey Drugs & Pharmaceuticals Ltd. specializes in manufacturing drugs and intermediates like metronidazole and nitro imidazole. Their product focus areas include Allergy, Dermatology, and Infectious Diseases.

Aarey Drugs & Pharma major competitors are Nectar Lifesciences, Everest Organics, Speciality Medicines, Sat Kartar Life, Syschem (India), Ambalal Sarabhai Ent, Gennex Lab.
Market Cap of Aarey Drugs & Pharma is ₹247 Crs.
While the median market cap of its peers are ₹246 Crs.

Aarey Drugs & Pharma seems to be less financially stable compared to its competitors.
Altman Z score of Aarey Drugs & Pharma is 3.5 and is ranked 4 out of its 8 competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Aarey Drugs & Pharmaceuticals Ltd.
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material